Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extramembranous Glomerulopathy”

137 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 137 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06614985
What this trial is testing

The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Renmin Hospital of Wuhan University 172
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Study completedNCT03804359
What this trial is testing

Personalized Medicine for Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Centre Hospitalier Universitaire de Nice 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642909
What this trial is testing

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd. 135
Large-scale testing (Phase 3)Study completedNCT00135967
What this trial is testing

Mycophenolate Mofetil in Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Radboud University Medical Center 30
Early research (Phase 1)Study completedNCT00805753
What this trial is testing

Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic 20
Large-scale testing (Phase 3)Study completedNCT01955187
What this trial is testing

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

Who this might be right for
MEMBRANOUS NEPHROPATHY
Hospital Universitario 12 de Octubre 86
Not applicableEnded earlyNCT03466801
What this trial is testing

The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.

Who this might be right for
Idiopathic Membranous Nephropathy
Wenhu Liu 6
Not applicableUnknownNCT05532111
What this trial is testing

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Who this might be right for
Efficacy and Safety
RenJi Hospital 60
Not applicableUnknownNCT01799460
What this trial is testing

Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Shanghai University of Traditional Chinese Medicine 80
Early research (Phase 1)Looking for participantsNCT06285279
What this trial is testing

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

Who this might be right for
Lupus NephritisANCA-associated VasculitisMembranous Nephropathy - PLA2R Induced+1 more
Nanjing University School of Medicine 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT05050214
What this trial is testing

Obinutuzumab in Primary MN

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 20
Not applicableWithdrawnNCT01093781
What this trial is testing

Aliskiren in Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Mayo Clinic
Not applicableUnknownNCT03549663
What this trial is testing

Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

Who this might be right for
Idiopathic Membranous Nephropathy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108
Large-scale testing (Phase 3)Active Not RecruitingNCT04629248
What this trial is testing

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Hoffmann-La Roche 142
Large-scale testing (Phase 3)Looking for participantsNCT05696613
What this trial is testing

SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc. 148
Large-scale testing (Phase 3)Study completedNCT01282073
What this trial is testing

Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Kyungpook National University Hospital 43
Not applicableUnknownNCT05667883
What this trial is testing

Prognostic Model of GC/CTX in the Treatment of MN

Who this might be right for
Idiopathic Membranous Nephropathy
Qianfoshan Hospital 50
Load More Results